search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
EXECUTIVE BRIEF


Costs at 12 Months: Key Wound Types 3M™


V.A.C.®


$200,000 $180,000 $160,000 $140,000 $120,000 $100,000 $80,000 $60,000 $40,000 $20,000 $0


Therapy patients had lower total and wound related costs across all wound types at 12 months


Total Costs Δ: $46,511 Wound Related Costs Δ: $27,167


Total Costs Δ: $27,762 Wound Related Costs Δ: $12,914


Total Costs Δ: $26,211 Wound Related Costs Δ: $6,069


Total Costs Δ: $25,307 Wound Related Costs Δ: $6,033


3M Wound Related Costs Non-Wound Related Costs Competitor Wound Related Costs Non-Wound Related Costs Non-healing


Surgical Wound p≤0.0001


V.A.C.® Open


Wound p≤0.0001


Therapy patients experienced shorter average length of therapy


Percentage of Patients who Remained on NPWT


60% 50% 40% 30% 20% 10% 0%


30 Days


25.7% fewer


35% fewer


3M Competitor


Pressure Injury


p≤0.0039 V.A.C.® Diabetic


Foot Ulcer p≤0.0001


Therapy patients were less likely to be switched to another NPWT supplier


Number of Patients who Switched NPWT Suppliers at 3 Months


140 120 100 80 60 40 20 0


2 Months 3 Months


3 Months p≤0.0001


For more information: contact your 3M Account Representative, visit 3M.com/KCI or call Technical Support at 1-800-275-4524.


References: 1. Law A, Cyhaniuk A, Krebs B. Comparison of health care costs and hospital readmission rates associated with negative pressure wound therapies. Wounds. 2015 Mar;27(3):63-72. PMID: 25786078.


3M Company 2510 Conway Ave St. Paul, MN 55144 USA


1.800.228.3957 3M.com/Medical


2. Law A L. Krebs B. Karnik B. Griffin L. Comparison of Healthcare Costs Associated With Patients Receiving Traditional Negative Pressure Wound Therapies in the Post Acute Setting. Cureus 12(11): e11790. DOI 10.7759/cureus.11790.


NOTE: Specific indications, contraindications, warnings, precautions, and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.


© 2021 3M. All rights reserved. 3M and the other marks shown are marks and/or registered marks. Unauthorized use prohibited. PRA-PM-US-03086 (07/21)


hpnonline.com • HEALTHCARE PURCHASING NEWS • September 2021 29


72% fewer


3M Competitor


Average Costs Percentage


Number of Patients


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54